(RMH) - EXTRACORPOREAL PHOTOPHERESIS SERVICEs

The Royal Marsden NHS Foundation Trust has completed a procurement process for Extracorporeal Photopheresis Services aimed at treating chronic and acute Graft versus Host Disease (GvHD) and Cutaneous T-Cell Lymphoma. The contract, under the category of services provided by blood banks, was awarded to NHS Blood and Transplant (NHSBT) for a total value of £10,000 and was signed on 28th March 2025. The procurement method utilised was a limited procedure without prior publication of a call for competition, reflecting a direct award strategy.

The main delivery location is The Royal Marsden NHS Trust in London, identified under region UKI33, and the procurement falls outside the scope of standard directive applications. This tender represents a valuable opportunity for specialised service providers in the healthcare sector focused on advanced medical treatments and blood services. The award highlights a need for enterprises that can offer highly specialised medical procedures, particularly those experienced with niche treatments like extracorporeal photopheresis.

Moreover, businesses looking to engage with public health organisations and NHS trusts might find similar opportunities rewarding, given the potential for establishing long-term service agreements with notable healthcare institutions. The emphasis on direct award procedures underlines the importance of developing specific expertise and relationships within the health service ecosystem.